Login to Your Account

First Parkinson's Gene Therapy Planned by Oxford Biomedica

By Nuala Moran

Wednesday, March 12, 2008
LONDON - Oxford Biomedica plc said the first patient is within days of being treated with ProSavin, its gene therapy treatment for Parkinson's disease. The neurosurgery required to administer it has been booked, but the company has agreed with the Henri Mondor Hospital in Paris where the trial is taking place not to disclose the actual date. (BioWorld International)

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription